News
Zacks.com on MSN18h
SAGE to be Acquired by Supernus Pharmaceuticals in $795 Million DealSUPN inks deal to acquire Sage Therapeutics for up to $795 million, securing rights to depression drug Zurzuvae.
Another patient has died from acute liver failure after receiving Sarepta’s gene therapy for DMD ; After a quiet start to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback